FIRM FIXED PRICENO SET ASIDE USED.

ELUSYS THERAPEUTICS INC - ANTHIM (OBILTOXAXIMAB)

PIID: 75A50324C00006
Signed Date: Jan 21, 2026Effective Date: May 1, 2024End Date: Closes in 934 days
Award $
$124.5M
Vendor
ELUSYS THERAPEUTICS INC
NAICS
325412
Signed Date
Jan 21, 2026

Key Details

Dollars Obligated
$124.5M
Base & All Options
Awarding Sub-Agency
Office of Assistant Secretary for Preparedness and Response
Product Service Code
6505 - DRUGS AND BIOLOGICALS
Extent Competed
NOT COMPETED
Number of Offers
1
Place of Performance
PARSIPPANY, NJ, 070541315, CD-NJ-11

Description

ANTHIM (OBILTOXAXIMAB)

Context & Analysis

On Jan 21, 2026, Department of Health and Human Services obligated $124,523,123.01 to ELUSYS THERAPEUTICS INC for anthim (obiltoxaximab). The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: not competed with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in PARSIPPANY, NJ. The contract is scheduled through Dec 31, 2028. This award is one of several similar procurements from Department of Health and Human Services under NAICS 325412 — related awards are listed below.

Contractor Information

UEI: ELP1DCK8L191
CAGE Code: 1WEK8
Location: PARSIPPANY, NJ
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related